Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Esomelone vs Nexium in Healthy Adults
NCT02543606Phase 4Completed
- Sponsor
- Yung Shin Pharmaceutical Industry
- Start
- Apr 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole in gastroesophageal reflux disease (GERD), sponsored by Yung Shin Pharmaceutical Industry. Started Apr 2015; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02543606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543606.